Plant expression platforms are being considered as a viable option for biopharmaceutical production, particularly in the global south. Research and developments in this area are ongoing, with studies highlighting both the advantages and challenges of using plant-based systems for producing therapeutic proteins. Various companies and systems, including non-traditional cell expression systems, are being explored for their potential in biopharmaceutical manufacturing.